GSK Australia Reports 2016 results to ASIC
Read more - GSK Australia Reports 2016 results to ASIC Read more
Press releases
These press releases are intended for business journalists and analysts/investors
Statement on arachnoiditis and myelograms
GSK has the utmost sympathy for the people who have been, and are, afflicted by arachnoiditis. It can be a very debilitating and painful condition.
Arachnoiditis has a range of possible causes such as spinal injury, surgery and infection. However, it is difficult to determine the causality of arachnoiditis.
Read more - Statement on arachnoiditis and myelograms Read more
GSK responds to Cyclone Debbie
Availability of Menveo (meningococcal ACWY vaccine)
Read more - Availability of Menveo (meningococcal ACWY vaccine) Read more
Bexsero® (Meningococcal B) vaccine availability
Read more - Bexsero® (Meningococcal B) vaccine availability Read more
GSK discloses $28,375 in payments to HCPs
Read more - GSK discloses $28,375 in payments to HCPs Read more
GSK increases supply of Menningococcal B vaccine
Read more - GSK increases supply of Menningococcal B vaccine Read more
New research shows Australians aren’t taking ageing lying down
Read more - New research shows Australians aren’t taking ageing lying down Read more
Luke Miels appointed President, Global Pharmaceuticals, GSK
Read more - Luke Miels appointed President, Global Pharmaceuticals, GSK Read more
New treatment option available January 1 2017 for patients with a form of severe asthma
First therapy approved for severe refractory eosinophilic asthma to be listed on the PBS